This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
ImmunoPrecise Antibodies Dividend
Dividend criteriumcontroles 0/6
Belangrijke informatie
n/a
Dividendrendement
n/a
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 0.3% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | n/a |
| Winst per aandeel | -CA$0.92 |
| Dividendrendementsvoorspelling | n/a |
Recente dividendupdates
Geen updates
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if IPA's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if IPA's dividend payments have been increasing.
Dividendrendement versus markt
| ImmunoPrecise Antibodies Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (IPA) | n/a |
| Markt onderkant 25% (CA) | 1.7% |
| Markt Top 25% (CA) | 5.8% |
| Gemiddelde industrie (Life Sciences) | 0.3% |
| Analist prognose (IPA) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate IPA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate IPA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as IPA has not reported any payouts.